메뉴 건너뛰기




Volumn 32, Issue 1, 2014, Pages 52-58

NIH inventions translate into drugs and biologics with high public health impact

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DRUG; FOMIVIRSEN; HEPATITIS A VACCINE; LYME DISEASE VACCINE; ROTAVIRUS VACCINE; VACCINE; ZALCITABINE;

EID: 84892157394     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2785     Document Type: Article
Times cited : (13)

References (23)
  • 2
    • 0001459704 scopus 로고
    • Real effects of academic research
    • Jaffe, A. Real effects of academic research. Am. Econ. Rev. 79, 957-970 (1989).
    • (1989) Am. Econ. Rev , vol.79 , pp. 957-970
    • Jaffe, A.1
  • 3
    • 0002034724 scopus 로고
    • Academic research and industrial innovation
    • Mansfield, E. Academic research and industrial innovation. Res. Policy 20, 1-12 (1991).
    • (1991) Res. Policy , vol.20 , pp. 1-12
    • Mansfield, E.1
  • 4
    • 84870343115 scopus 로고    scopus 로고
    • The economic impact of licensed commercialized inven-tions originating in university research
    • Roessner, D., Bond, J., Okubo, S. & Planting, M. The economic impact of licensed commercialized inven-tions originating in university research. Res. Policy 42, 23-34 (2013).
    • (2013) Res. Policy , vol.42 , pp. 23-34
    • Roessner, D.1    Bond, J.2    Okubo, S.3    Planting, M.4
  • 5
    • 30544437182 scopus 로고    scopus 로고
    • The licensing of DNA patents by US academic institutions: An empirical survey
    • Pressman, L. et al. The licensing of DNA patents by US academic institutions: an empirical survey. Nat. Biotechnol. 24, 31-39 (2006).
    • (2006) Nat. Biotechnol , vol.24 , pp. 31-39
    • Pressman, L.1
  • 6
    • 80051548581 scopus 로고    scopus 로고
    • 30 years after Bayh-Dole: Reassessing academic entrepreneurship
    • Grimaldi, R., Kenney, M., Siegel, D.S. & Wright, M. 30 years after Bayh-Dole: reassessing academic entrepreneurship. Res. Policy 40, 1045-1057 (2011).
    • (2011) Res. Policy , vol.40 , pp. 1045-1057
    • Grimaldi, R.1    Kenney, M.2    Siegel, D.S.3    Wright, M.4
  • 9
    • 58149242549 scopus 로고    scopus 로고
    • Academic patents and access to medicines in developing countries
    • Sampat, B.N. Academic patents and access to medicines in developing countries. Am. J. Public Health 99, 9-17 (2009).
    • (2009) Am. J. Public Health , vol.99 , pp. 9-17
    • Sampat, B.N.1
  • 10
    • 76149092908 scopus 로고    scopus 로고
    • Private sector contributions to pharmaceutical science: Thirty-five summary case histories
    • Zycher, B., DiMasi, J.A. & Milne, C.-P. Private sector contributions to pharmaceutical science: thirty-five summary case histories. Am. J. Ther. 17, 101-120 (2010).
    • (2010) Am. J. Ther , vol.17 , pp. 101-120
    • Zycher, B.1    Dimasi, J.A.2    Milne, C.-P.3
  • 11
    • 78049467253 scopus 로고    scopus 로고
    • The importance of new companies for drug discovery: Origins of a decade of new drugs
    • Kneller, R. The importance of new companies for drug discovery: origins of a decade of new drugs. Nat. Rev. Drug Discov. 9, 867-882 (2010).
    • (2010) Nat. Rev. Drug Discov , vol.9 , pp. 867-882
    • Kneller, R.1
  • 12
    • 79955636638 scopus 로고    scopus 로고
    • What are the respective roles of the public and private sectors in pharmaceutical innovation?
    • Sampat, B.N. & Lichtenberg, F.R. What are the respective roles of the public and private sectors in pharmaceutical innovation? Health Aff. 30, 332-339 (2011).
    • (2011) Health Aff , vol.30 , pp. 332-339
    • Sampat, B.N.1    Lichtenberg, F.R.2
  • 15
    • 80053219051 scopus 로고    scopus 로고
    • An empirical review of major legislation affecting drug development: Past experiences, effects and unintended consequences
    • Kesselheim, A.S. An empirical review of major legislation affecting drug development: past experiences, effects and unintended consequences. Milbank Q. 89, 450-502 (2011).
    • (2011) Milbank Q , vol.89 , pp. 450-502
    • Kesselheim, A.S.1
  • 18
    • 84892188648 scopus 로고    scopus 로고
    • National Institutes of Health Office of Technology Transfer
    • National Institutes of Health Office of Technology Transfer. Fludara The New Benchmark: A Case Study. http://www.ott.nih.gov/sites/default/files/ documents/pdfs/FludaraCS.pdf (2003).
    • (2003) Fludara the New Benchmark: A Case Study
  • 19
    • 73949089207 scopus 로고    scopus 로고
    • Financial anatomy of biomedical research 2003-2008
    • Dorsey, E.R. et al. Financial anatomy of biomedical research 2003-2008. J. Am. Med. Assoc. 303, 137-143 (2010).
    • (2010) J. Am. Med. Assoc , vol.303 , pp. 137-143
    • Dorsey, E.R.1
  • 20
    • 2942595810 scopus 로고    scopus 로고
    • Abbott defends Norvir price hike
    • Mullin, R. Abbott defends Norvir price hike. Chem. Eng. News 82, 6 (2004).
    • (2004) Chem. Eng. News , vol.82 , pp. 6
    • Mullin, R.1
  • 23
    • 84892162010 scopus 로고    scopus 로고
    • National Institutes of Health. Actual Obligations by Institute and Center, FY 2000-FY 2012
    • National Institutes of Health. Actual Obligations by Institute and Center, FY 2000-FY 2012 (2010).
    • (2010)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.